What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Immune system
Mark A. Atkinson mostly deals with Immunology, Type 1 diabetes, Diabetes mellitus, Internal medicine and Endocrinology.
His study involves Autoimmunity, Autoantibody, Immune system, Autoimmune disease and Antigen, a branch of Immunology.
His study explores the link between Type 1 diabetes and topics such as Disease that cross with problems in Natural history and Developmental psychology.
He combines subjects such as Surgery and Intensive care medicine with his study of Diabetes mellitus.
The study incorporates disciplines such as Nephropathy and Oncology in addition to Internal medicine.
His Endocrinology research includes elements of Antibody, IL-2 receptor and Cytokine.
His most cited work include:
- Type 1 Diabetes (1294 citations)
- Type 1 diabetes: new perspectives on disease pathogenesis and treatment (1200 citations)
- Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes (1000 citations)
What are the main themes of his work throughout his whole career to date?
Mark A. Atkinson mainly focuses on Type 1 diabetes, Immunology, Diabetes mellitus, Internal medicine and Endocrinology.
His research in Type 1 diabetes focuses on subjects like Disease, which are connected to Natural history.
His work in Immunology addresses issues such as Islet, which are connected to fields such as Transplantation.
As a part of the same scientific study, Mark A. Atkinson usually deals with the Diabetes mellitus, concentrating on Intensive care medicine and frequently concerns with Clinical trial.
His research in Endocrinology intersects with topics in Antibody, Cytokine and Insulin dependent diabetes.
His studies deal with areas such as Adoptive cell transfer and Insulitis as well as NOD mice.
He most often published in these fields:
- Type 1 diabetes (49.74%)
- Immunology (46.56%)
- Diabetes mellitus (35.10%)
What were the highlights of his more recent work (between 2018-2021)?
- Type 1 diabetes (49.74%)
- Diabetes mellitus (35.10%)
- Internal medicine (34.57%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Type 1 diabetes, Diabetes mellitus, Internal medicine, Pancreas and Islet.
His work deals with themes such as Autoantibody, C-peptide, Immunology and Autoimmunity, Disease, which intersect with Type 1 diabetes.
Mark A. Atkinson is studying Antigen, which is a component of Immunology.
The Diabetes mellitus study combines topics in areas such as Intensive care medicine, MEDLINE and Pathology.
He has included themes like Gastroenterology and Endocrinology in his Internal medicine study.
His Islet study also includes fields such as
- Immune system which connect with Cancer research, Nod and Cytotoxic T cell,
- Bioinformatics which connect with Hormone.
Between 2018 and 2021, his most popular works were:
- The human body at cellular resolution: the NIH Human Biomolecular Atlas Program (95 citations)
- Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes (87 citations)
- Mapping the Human Body at Cellular Resolution -- The NIH Common Fund Human BioMolecular Atlas Program (86 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Immune system
Type 1 diabetes, Diabetes mellitus, Autoimmunity, Disease and Immune system are his primary areas of study.
His research investigates the link between Type 1 diabetes and topics such as Type 2 diabetes that cross with problems in Obesity.
He has researched Diabetes mellitus in several fields, including Pancreas, Internal medicine, Pathogenesis, Pathology and Endocrine system.
His Internal medicine study incorporates themes from SNP, Autoantibody and Endocrinology.
His Autoimmunity study is concerned with the larger field of Immunology.
His study in Immunology is interdisciplinary in nature, drawing from both Microbiome and Genotype, Haplotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
